 WALTHAM, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Dyne Therapeutics, Inc. Nasdaq: DYN, a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference being held in New York, NY on Monday, September 12, 2022 at 2:15 p.m. ET. 